BridgeBio Pharma Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
33.87
0.02
(0.06%)
Volume:
1,410,669
52 week range:
21.62 - 39.47
Market Cap:
6.442B
Company Description:
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a stabilizer of transthyretin, or TTR.